ADRB2 and psoriasis: This reaffirmed that FGF10 exerts an effect on psoriasis severity and that disruption of normal β-AR activity—as observed in chronic diseases like rheumatoid arthritis or psoriasis—can allow for this effect to rise above the normal anti-inflammatory actions, otherwise keeping it in check.